Swedbank AB Sells 71,461 Shares of HCA Healthcare, Inc. $HCA

Swedbank AB decreased its position in HCA Healthcare, Inc. (NYSE:HCA) by 29.0% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 174,820 shares of the company’s stock after selling 71,461 shares during the period. Swedbank AB owned about 0.07% of HCA Healthcare worth $74,508,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in HCA. Park Place Capital Corp increased its position in HCA Healthcare by 2,336.0% during the second quarter. Park Place Capital Corp now owns 1,218 shares of the company’s stock valued at $474,000 after acquiring an additional 1,168 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of HCA Healthcare by 11.9% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,454 shares of the company’s stock worth $8,796,000 after purchasing an additional 2,698 shares in the last quarter. Swiss National Bank grew its position in shares of HCA Healthcare by 4.3% during the second quarter. Swiss National Bank now owns 558,900 shares of the company’s stock worth $214,115,000 after purchasing an additional 23,100 shares in the last quarter. Cherokee Insurance Co bought a new stake in shares of HCA Healthcare during the second quarter valued at approximately $3,869,000. Finally, Harrell Investment Partners LLC lifted its stake in HCA Healthcare by 176.3% in the 2nd quarter. Harrell Investment Partners LLC now owns 1,815 shares of the company’s stock worth $695,000 after purchasing an additional 1,158 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Stock Up 0.0%

HCA Healthcare stock opened at $474.06 on Thursday. The firm has a market capitalization of $108.18 billion, a price-to-earnings ratio of 18.32, a PEG ratio of 1.40 and a beta of 1.36. The company has a fifty day simple moving average of $473.53 and a 200-day simple moving average of $418.93. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $520.00.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, beating the consensus estimate of $5.64 by $1.32. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The firm had revenue of $19.16 billion for the quarter, compared to analysts’ expectations of $18.55 billion. During the same quarter in the previous year, the company posted $4.90 EPS. The company’s revenue was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, research analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, December 29th. Shareholders of record on Monday, December 15th will be issued a dividend of $0.72 per share. The ex-dividend date is Monday, December 15th. This represents a $2.88 annualized dividend and a yield of 0.6%. HCA Healthcare’s dividend payout ratio is 11.13%.

Analyst Ratings Changes

A number of brokerages have issued reports on HCA. The Goldman Sachs Group upped their price objective on HCA Healthcare from $470.00 to $520.00 and gave the company a “buy” rating in a research report on Monday, October 27th. Mizuho increased their price objective on HCA Healthcare from $505.00 to $520.00 and gave the stock an “outperform” rating in a research note on Thursday, December 18th. UBS Group boosted their price target on shares of HCA Healthcare from $495.00 to $525.00 and gave the company a “buy” rating in a report on Monday, October 27th. Stephens lifted their target price on HCA Healthcare from $450.00 to $500.00 and gave the company an “overweight” rating in a research note on Monday, October 27th. Finally, Jefferies Financial Group upped their price target on HCA Healthcare from $485.00 to $525.00 and gave the stock a “buy” rating in a research report on Tuesday, October 28th. Fourteen analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, HCA Healthcare has a consensus rating of “Moderate Buy” and an average price target of $479.00.

Insiders Place Their Bets

In other news, EVP Michael R. Mcalevey sold 3,892 shares of the firm’s stock in a transaction on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total value of $1,843,990.68. Following the sale, the executive vice president directly owned 3,487 shares in the company, valued at approximately $1,652,105.73. This trade represents a 52.74% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 1.30% of the stock is currently owned by company insiders.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.